Maryles Joel Michael Insider Trades

Insider Trading History

Track insider trading activity for Maryles Joel Michael. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Chemomab Therapeutics
Chemomab Therapeutics CMMB
Director
Holding Value $12.3k 6,820 shares
Last Trade
May 24, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.1k 6,820 shares
$2.80
$1.80
Chemomab Therapeutics
Chemomab Therapeutics CMMB
Director
Holding Value $2.58k 1,433 shares
Last Trade
May 24, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$91.1 33 shares
$2.76
$1.80
Chemomab Therapeutics
Chemomab Therapeutics CMMB
Director
Holding Value $21.4k 11,884 shares
Last Trade
Mar 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$53.2k 11,884 shares
$4.48
$1.80
Chemomab Therapeutics
Chemomab Therapeutics CMMB
Director
Holding Value $1.8k 1,000 shares
Last Trade
Mar 18, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.18k 500 shares
$4.36
$1.80
Chemomab Therapeutics
Chemomab Therapeutics CMMB
Director
Holding Value $21.4k 11,884 shares
Last Trade
Mar 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$42k 11,884 shares
$3.53
$1.80
Chemomab Therapeutics
Chemomab Therapeutics CMMB
Director
Holding Value $21.4k 11,884 shares
Last Trade
Apr 19, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$410k 11,884 shares
$34.49
$1.80

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up